AAAAAA
Results:
1-12
|
Results: 12
Authors:
Ylisirnio, S
Hoyhtya, M
Makitaro, R
Paakko, P
Risteli, J
Kinnula, VL
Turpeenniemi-Hujanen, T
Jukkola, A
Citation: S. Ylisirnio et al., Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer, CLIN CANC R, 7(6), 2001, pp. 1633-1637
Authors:
Koskinen, SOA
Hoyhtya, M
Turpeenniemi-Hujanen, T
Martikkala, V
Makinen, TT
Oksa, J
Rintamaki, H
Lofberg, M
Somer, H
Takala, TES
Citation: Soa. Koskinen et al., Serum concentrations of collagen degrading enzymes and their inhibitors after downhill running, SC J MED SC, 11(1), 2001, pp. 9-15
Authors:
Sassi, ML
Jukkola, A
Riekki, R
Hoyhtya, M
Risteli, L
Oikarinen, A
Risteli, J
Citation: Ml. Sassi et al., Type I collagen turnover and cross-linking are increased in irradiated skin of breast cancer patients, RADIOTH ONC, 58(3), 2001, pp. 317-323
Authors:
Kalela, A
Laaksonen, R
Lehtimaki, T
Koivu, TA
Hoyhtya, M
Janatuinen, T
Pollanen, P
Vesalainen, R
Saikku, P
Knuuti, J
Nikkari, ST
Citation: A. Kalela et al., Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases, AM J CARD, 88(2), 2001, pp. 173
Authors:
Oberg, A
Hoyhtya, M
Tavelin, B
Stenling, R
Lindmark, G
Citation: A. Oberg et al., Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer, ANTICANC R, 20(2B), 2000, pp. 1085-1091
Authors:
Ylisirnio, S
Hoyhtya, M
Turpeenniemi-Hujanen, T
Citation: S. Ylisirnio et al., Serum matrix metalloproteinases-2,-9 and tissue inhibitors of metalloproteinases-1,-2 in lung cancer - TIMP-1 as a prognostic marker, ANTICANC R, 20(2B), 2000, pp. 1311-1316
Authors:
Jaalinoja, J
Herva, R
Korpela, M
Hoyhtya, M
Turpeenniemi-Hujanen, T
Citation: J. Jaalinoja et al., Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms, J NEURO-ONC, 46(1), 2000, pp. 81-90
Authors:
Kalela, A
Ponnio, M
Koivu, TA
Hoyhtya, M
Huhtala, H
Sillanaukee, P
Nikkari, ST
Citation: A. Kalela et al., Association of serum sialic acid and MMP-9 with lipids and inflammatory markers, EUR J CL IN, 30(2), 2000, pp. 99-104
Authors:
Riekki, R
Jukkola, A
Sassi, ML
Hoyhtya, M
Kallioinen, M
Risteli, J
Oikarinen, A
Citation: R. Riekki et al., Modulation of skin collagen metabolism by irradiation: collagen synthesis is increased in irradiated human skin, BR J DERM, 142(5), 2000, pp. 874-880
Authors:
Westerlund, A
Apaja-Sarkkinen, M
Hoyhtya, M
Puistola, U
Turpeenniemi-Hujanen, T
Citation: A. Westerlund et al., Gelatinase A-immunoreactive protein in ovarian lesions - Prognostic value in epithelial ovarian cancer, GYNECOL ONC, 75(1), 1999, pp. 91-98
Authors:
Talvensaari-Mattila, A
Apaja-Sarkkinen, M
Hoyhtya, M
Westerlund, A
Puistola, U
Turpeenniemi-Hujanen, T
Citation: A. Talvensaari-mattila et al., Matrix metalloproteinase 2 immunoreactive protein appears early in cervical epithelial dedifferentiation, GYNECOL ONC, 72(3), 1999, pp. 306-311
Authors:
Vaisanen, A
Kallioinen, M
von Dickhoff, K
Laatikainen, L
Hoyhtya, M
Turpeenniemi-Hujanen, T
Citation: A. Vaisanen et al., Matrix metalloproteinase-2 (MMP-2) immunoreactive protein - A new prognostic marker in uveal melanoma?, J PATHOLOGY, 188(1), 1999, pp. 56-62
Risultati:
1-12
|